NIH-funded research R21 grant

Understanding Brain Signals in Schizophrenia

Official title: Distinct NMDA receptor signaling domains regulate hippocampal network dynamics

Funded at George Mason University · NIH-11145190 · Data updated 2026-11-12

This project aims to understand how specific brain signals in a part of the brain called the hippocampus contribute to symptoms of schizophrenia, especially memory problems.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionGeorge Mason University
NIH-funded
Lab location1 site (Fairfax, United States)
Project startAugust 1, 2024
Project endJuly 31, 2026
Funding year2025
Award (this year)$191,448
NIH project number5R21MH135232-02
Project IDNIH-11145190 on NIH RePORTER

Who could benefit from this research

Could help

This foundational research is focused on understanding the brain mechanisms underlying schizophrenia, particularly in individuals who experience symptoms in late adolescence to early adulthood.

Less likely to help

Patients will not directly participate in this basic science project, so there is no immediate direct benefit for individuals.

What this research studies

Our brains use special signals, like those from NMDA receptors, to help us think and remember. In people with schizophrenia, these signals don't always work correctly, especially in the hippocampus, a brain area important for memory. This project explores how different parts of these NMDA receptor signals affect brain activity and memory. By understanding these detailed brain processes, we hope to uncover new ways to help people experiencing schizophrenia.

Why it matters

Potential benefit: If successful, this work could lead to a deeper understanding of schizophrenia, potentially paving the way for new treatments that target specific brain signaling pathways to improve cognitive symptoms.

How similar studies have gone: Other studies have implicated NMDA receptor dysfunction in schizophrenia, and this project builds upon that knowledge by exploring the specific roles of different signaling components.

Where this research is happening

  • George Mason University
    Fairfax, United States
    Active

Researchers

  • Principal investigator: Dumas, Theodore C — George Mason University
  • Study coordinator: Dumas, Theodore C

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.